152 related articles for article (PubMed ID: 37174084)
1. A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.
Bui N; Dietz H; Farag S; Hirbe AC; Wagner MJ; Van Tine BA; Ganjoo K; Jones RL; Keedy VL; Davis EJ
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174084
[TBL] [Abstract][Full Text] [Related]
2. Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response.
Singh A; Thorpe SW; Darrow M; Carr-Ascher JR
Front Oncol; 2022; 12():991724. PubMed ID: 36465334
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.
Kozawa E; Nishida Y; Kawai A; Hayakawa K; Setsu N; Kawashima H; Iwata S; Tsuchiya H; Tsukushi S; Takenaka S; Imanishi J; Baba I; Nagano A; Morii T; Shirai T; Shimizu K; Kawano H
Cancer Sci; 2022 Jul; 113(7):2397-2408. PubMed ID: 35485870
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
[TBL] [Abstract][Full Text] [Related]
5. Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
Hompland I; Ferrari S; Bielack S; Palmerini E; Hall KS; Picci P; Hecker-Nolting S; Donati DM; Blattmann C; Bjerkehagen B; Staals E; Kager L; Gambarotti M; Kühne T; Eriksson M; Ferraresi V; Kevric M; Biagini R; Baumhoer D; Brosjø O; Comandone A; Schwarz R; Bertulli R; Kessler T; Hansson L; Apice G; Heydrich BN; Setola E; Flörcken A; Ruggieri P; Krasniqi F; Hofmann-Wackersreuther G; Casali P; Reichardt P; Smeland S
Eur J Cancer; 2021 Jul; 151():150-158. PubMed ID: 33990016
[TBL] [Abstract][Full Text] [Related]
6. Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?
Kawaguchi S; Sun T; Lin PP; Deavers M; Harun N; Lewis VO
Clin Orthop Relat Res; 2014 Mar; 472(3):983-9. PubMed ID: 24197392
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials.
Zając W; Dróżdż J; Kisielewska W; Karwowska W; Dudzisz-Śledź M; Zając AE; Borkowska A; Szumera-Ciećkiewicz A; Szostakowski B; Rutkowski P; Czarnecka AM
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568740
[TBL] [Abstract][Full Text] [Related]
8. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
[TBL] [Abstract][Full Text] [Related]
10. Dedifferentiated chondrosarcoma with minimal or small dedifferentiated component.
Dehner CA; Maloney N; Amini B; Jennings JW; McDonald DJ; Wang WL; Chrisinger JSA
Mod Pathol; 2022 Jul; 35(7):922-928. PubMed ID: 35115636
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.
Emori M; Nakahashi N; Takasawa A; Murata K; Murahashi Y; Shimizu J; Tsukahara T; Sugita S; Takada K; Hasegawa T; Osanai M; Iba K
Hum Cell; 2023 Nov; 36(6):2195-2203. PubMed ID: 37454032
[TBL] [Abstract][Full Text] [Related]
12. Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Stacchiotti S; Ferrari S; Redondo A; Hindi N; Palmerini E; Vaz Salgado MA; Frezza AM; Casali PG; Gutierrez A; Lopez-Pousa A; Grignani G; Italiano A; LeCesne A; Dumont S; Blay JY; Penel N; Bernabeu D; de Alava E; Karanian M; Morosi C; Brich S; Dagrada GP; Vallacchi V; Castelli C; Brenca M; Racanelli D; Maestro R; Collini P; Cruz J; Martin-Broto J
Lancet Oncol; 2019 Sep; 20(9):1252-1262. PubMed ID: 31331701
[TBL] [Abstract][Full Text] [Related]
13. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Tawbi HA; Burgess M; Bolejack V; Van Tine BA; Schuetze SM; Hu J; D'Angelo S; Attia S; Riedel RF; Priebat DA; Movva S; Davis LE; Okuno SH; Reed DR; Crowley J; Butterfield LH; Salazar R; Rodriguez-Canales J; Lazar AJ; Wistuba II; Baker LH; Maki RG; Reinke D; Patel S
Lancet Oncol; 2017 Nov; 18(11):1493-1501. PubMed ID: 28988646
[TBL] [Abstract][Full Text] [Related]
14. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
[TBL] [Abstract][Full Text] [Related]
15. Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
van Maldegem A; Conley AP; Rutkowski P; Patel SR; Lugowska I; Desar IME; Bovée JVMG; Gelderblom H
Oncologist; 2019 Jan; 24(1):110-116. PubMed ID: 30082492
[TBL] [Abstract][Full Text] [Related]
16. Primary dedifferentiated chondrosarcoma of the lung with a 4-year history of breast cancer: A case report.
Wen H; Gong FJ; Xi JM
World J Clin Cases; 2023 May; 11(13):3022-3028. PubMed ID: 37215415
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated Chondrosarcoma of Proximal Tibia and Fibula with an Infected Ulcer: A Case Report.
Pattanashetty OB; B B D; Pillai A; Endigeri P
J Orthop Case Rep; 2016; 6(2):9-12. PubMed ID: 27703929
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution.
Miao R; Choy E; Raskin KA; Schwab JH; Nielsen GP; Deshpande V; Chebib I; DeLaney TF; Hornicek FJ; Cote GM; Chen YE
Sarcoma; 2019; 2019():9069272. PubMed ID: 31915413
[TBL] [Abstract][Full Text] [Related]
19. Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report.
Yonezawa H; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Morinaga S; Asano Y; Saito S; Tome Y; Ikeda H; Nojima T; Tsuchiya H
World J Clin Cases; 2022 Apr; 10(10):3297-3305. PubMed ID: 35647122
[TBL] [Abstract][Full Text] [Related]
20. Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?
Song K; Song J; Chen F; Lin K; Ma X; Jiang J
Clin Orthop Relat Res; 2019 Mar; 477(3):573-583. PubMed ID: 30762691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
